Do you have event related questions or need help with registration?
This is your last chance to obtain live continuing educational credits for pharmacy license renewal. This knowledge-based continuing education program (offered via Webex) will update the participant regarding Hyperlipidemia, OUD, DVT, Update on New Drugs, and Off Label Use of Migraine Medicine. Don't miss this very relevant information!
7:15 AM | Registration/Connect |
8:00 AM | Lipid On A Prayer: Current Recommendations for Treating Patients with Hyperlipidemia- Garrett Allegra, PharmD |
9:00 AM | The New Era of Opioid Use Disorder- Olivia Caron, PharmD, BCACP, CPP |
10:00 AM | Break |
10:15 AM | Breaking Down DVT: Tailoring Treatment for Special Populations- Caroline McKenna, PharmD |
11:15 AM | Update on New Drugs 2024- Avery Weekman, PharmD |
12:15 PM | Break |
12:30 PM | When Off Label Makes Good Migraine Medicine- Brian Loftus, MD |
1:30 PM | Adjourn |
![]() |
|
Describe the epidemiology, pathophysiology, and complications of hyperlipidemia (P/PT) |
|
Construct a treatment regimen for a given patient case based on AHA/ACC guideline recommendations (P) |
|
Examine common myths related to the use of buprenorphine and highlight novel induction strategies (P/PT) |
|
Develop treatment plans for VTE in the context of patient-specific comorbidities (P) |
|
List 8 medications that were newly approved by the FDA in 2024 (P/PT) |
|
Describe the dosing, precautions, common side effects, and key patient counseling points for these medications (P) |
|
Review Topiramate over 100 mg (P) |
|
Recognize available treatments for hyperlipidemia and their associated class, mechanism of action, and dosing recommendations (P/PT) |
|
Summarize and compare medications for opioid use disorder (P/PT) |
|
Apply non-stigmatizing harm reduction concepts to patient cases (P) |
|
Discuss the importance of monitoring for patient safety, including appropriate lab testing, and s/sx of clotting and bleeding (P) |
|
Review the mechanism of action of these medications and their role in their respective disease states (P/PT) |
|
Discuss the myth of triptan overuse headache (P) |
|
Review Zonisamide, Duloxetine/Desvenlafaxine, and Candesartan for migraine prevention (P) |
Early Registration Fee- Pharmacists
$89.00Early Registration Fee- Pharmacy Techs
$59.00Registration Fee- Pharmacists
$104.00Registration Fee- Pharmacy Techs
$74.00Pharmacists and Pharmacy Technicians in all aspects of Pharmacy
MAHEC has a pay-up-front policy for all CE programs. The only exceptions will be for pre-approved programs where an individual payment plan is appropriate. Registrations received without accompanying payment will not be processed and participants who have not paid the course fee will not be admitted into the program.
Unless otherwise noted in course materials, the following cancellation policy applies to all programs: